Gilead Sciences (NASDAQ: GILD) Looks Poised For a Surge
Our target potential upside is 8% to 23% in the next 3-5 months.
Read MorePosted by Tara Young, Trades Of The Day | Feb 8, 2021
Our target potential upside is 8% to 23% in the next 3-5 months.
Read MorePosted by Tara Young, Trades Of The Day | Feb 4, 2021
Our target potential upside is nearly 10% to 20% in the next 3-6 months.
Read MorePosted by Tara Young, Trades Of The Day | Feb 3, 2021
Our target potential upside is nearly 7% to 17% in the next 3-6 months.
Read MorePosted by Tara Young, Trades Of The Day | Feb 2, 2021
Our target potential upside is nearly 23% to 56% in the next 3-6 months.
Read MorePosted by Tara Young, Trades Of The Day | Feb 1, 2021
Our target potential upside is 5% to 11% in the next 3-6 months.
Read More